EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ness, G. C.
Right arrow Articles by Gertz, K. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ness, G. C.
Right arrow Articles by Gertz, K. R.
Experimental Biology and Medicine 229:412-416 (2004)
© 2004 Society for Experimental Biology and Medicine


ORIGINAL RESEARCH ARTICLE

Hepatic HMG-CoA Reductase Expression and Resistance to Dietary Cholesterol

Gene C. Ness1, and Karen R. Gertz

Department of Biochemistry and Molecular Biology, College of Medicine, University of South Florida, Tampa, Florida 33612

To whom requests for reprints should be addressed at 1 Department of Biochemistry and Molecular Biology, College of Medicine, University of South Florida, 12901 Bruce B. Downs Blvd., Tampa, FL 33612. E-mail: gness{at}hsc.usf.edu

The premise that the intrinsic level of expression of hepatic 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase determines the relative sensitivity to the serum cholesterol raising action of dietary cholesterol was examined in 9 strains of rat. For further comparison purposes, hamsters were also examined. The basal expression of hepatic HMG-CoA reductase, extent of feedback regulation by cholesterol, and changes in serum cholesterol levels and the hepatic low-density lipoprotein (LDL) receptor in response to cholesterol challenge were determined in these animals. The Sprague-Dawley, Wistar-Furth, Spontaneously Hypertensive, Lewis, and Wistar-Kyoto rats were all very resistant to dietary cholesterol and exhibited hepatic HMG-CoA reductase activities above 150 pmol / min–1 / mg–1. The Buffalo, Brown Norway, and Copenhagen 2331 rats had hepatic HMG-CoA reductase activities below 90 pmol / min–1 / mg–1 and had increases in serum cholesterol levels ranging from 12 to 33 mg/dl when given a 4-day, 1% cholesterol challenge. The extent of feedback regulation was reduced to only 3-fold in the Fisher 344 and Brown Norway rats that exhibited significant increases in serum cholesterol levels when given a cholesterol challenge. The Golden Syrian hamsters exhibited the largest increase (197 mg/dl) in serum cholesterol levels in response to dietary cholesterol and the lowest basal expression of hepatic HMG-CoA reductase (3.3 pmol / min–1 / mg–1). Hepatic LDL receptor levels were not significantly decreased by dietary cholesterol in any of the animals. The data from these inbred rats and the hamsters strongly support the conclusion that the animals expressing the highest levels of hepatic HMG-CoA reductase are the most resistant to the serum cholesterol raising action of dietary cholesterol.

Key Words: hepatic HMG-CoA reductase • LDL receptor • inbred strains of rat • feedback regulation • serum cholesterol




This article has been cited by other articles:


Home page
J. Nutr.Home page
M. Torres-Gonzalez, S. Shrestha, M. Sharman, H. C. Freake, J. S. Volek, and M. L. Fernandez
Carbohydrate Restriction Alters Hepatic Cholesterol Metabolism in Guinea Pigs Fed a Hypercholesterolemic Diet
J. Nutr., October 1, 2007; 137(10): 2219 - 2223.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
W. R. Lagor, R. Heller, E. D. De Groh, and G. C. Ness
Functional Analysis of the Hepatic HMG-CoA Reductase Promoter by In Vivo Electroporation
Experimental Biology and Medicine, March 1, 2007; 232(3): 353 - 361.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
L. S. Correa-Cerro, C. A. Wassif, L. Kratz, G. F. Miller, J. P. Munasinghe, A. Grinberg, S. J. Fliesler, and F. D. Porter
Development and characterization of a hypomorphic Smith-Lemli-Opitz syndrome mouse model and efficacy of simvastatin therapy
Hum. Mol. Genet., March 15, 2006; 15(6): 839 - 851.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. R. Lagor, E. D. de Groh, and G. C. Ness
Diabetes Alters the Occupancy of the Hepatic 3-Hydroxy-3-methylglutaryl-CoA Reductase Promoter
J. Biol. Chem., November 4, 2005; 280(44): 36601 - 36608.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Society for Experimental Biology and Medicine.